Patent Assignment
Reel/Frame 057697/0758
Change of Name
Recorded: 2021-10-04
Pages: 5
Assignor
APICORE US LLC
Executed: 2019-07-11
Assignee
MYLAN API US LLC
1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Covered Properties
(55)
Process for Preparation of 5H-Dibenzo[a,D] Cycloheptene Derivatives
PCT:
PCT/US2007/084049 ↗
Process for Preparation of Isosulfan Blue
PCT:
PCT/US2007/084051 ↗
Process for the Preparation of Cis-2-Methylspiro (1, 3-Oxathiolane 5-3) Quinuclidine
PCT:
PCT/US2011/036631 ↗
Process for Preparing Heparinoids and Intermediates Useful in the Synthesis Thereof
PCT:
PCT/US2012/041540 ↗
Methods of Making Netupitant and Intermediates Thereof
PCT:
PCT/US2015/029028 ↗
Methods of Making Carfilzomib and Intermediates Thereof
PCT:
PCT/US2015/057381 ↗
Process of Making Regadenoson and Novel Polymorph Thereof
PCT:
PCT/US2016/016217 ↗
Processes for Making Ponatinib and Intermediates Thereof
PCT:
PCT/US2016/036857 ↗
Extended Release Molindone Compositions
PCT:
PCT/US2018/041414 ↗
Process for Preparation of 5H-Dibenzo[a,D] Cycloheptene Derivatives
Process for Preparation of Isosulfan Blue
Application:
11/747,291 →
Publication:
US 2008/0281127
PROCESS FOR PREPARATION OF 5H DIBENZO[a,d] CYCLOHEPTENE DERIVATIVES
Application:
12/138,924 →
Publication:
US 2008/0242892
Process for Preparation Isosulfan Blue
Process for Preparation of Isosulfan Blue
Application:
12/643,056 →
Publication:
US 2010/0094044
Process for the Preparation of Cis-2-Methylspiro (1, 3-Oxathiolane 5-3') Quinuclidine
Process for Preparing Heparinoids and Intermediates Useful in the Synthesis Thereof
Application:
13/170,471 →
Publication:
US 2013/0005954
Process for Preparation of Isosulfan Blue
Cis-2-Methylspiro 1, 3-Oxathiolane 5-3 Quinuclidine
Application:
13/873,833 →
Publication:
US 2013/0237707
Process for Preparation of Isosulfan Blue
Processes for Making Ponatinib and Intermediates Thereof
Application:
14/279,607 →
Publication:
US 2014/0343282
Process for Preparing Heparinoids and Intermediates Useful in the Synthesis Thereof
Application:
14/338,927 →
Publication:
US 2014/0336369
Methods of Making Netupitant and Intermediates Thereof
Application:
14/703,178 →
Publication:
US 2015/0315149
Methods of Making Carfilzomib and Intermediates Thereof
Application:
14/923,068 →
Publication:
US 2016/0115198
Processes for Making Ponatinib and Intermediates Thereof
Process of Making Regadenoson and Novel Polymorph Thereof
Process for Preparation of Isosulfan Blue
Application:
15/095,791 →
Publication:
US 2016/0221936
Processes for Making Ponatinib and Intermediates Thereof
Methods of Making Carfilzomib and Intermediates Thereof
Methods of Making Netupitant and Intermediates Thereof
Application:
15/257,261 →
Publication:
US 2016/0368875
Methods of Making Netupitant and Intermediates Thereof
Application:
15/273,832 →
Publication:
US 2017/0008848
Process for Preparation and Purification of Pomalidomide
Application:
15/452,444 →
Publication:
US 2017/0260157
Processes for Making Ponatinib and Intermediates Thereof
Application:
15/785,613 →
Publication:
US 2018/0044345
Methods of Making Carfilzomib and Intermediates Thereof
Application:
15/785,966 →
Publication:
US 2018/0037606
Novel Polymorph of Regadenoson and Process for Preparation Thereof
Process for Preparation of Isosulfan Blue
Process and Novel Polymorphic Form of Vortioxetine and Its Pharmaceutically Acceptable Salts
Novel polymorphs of ponatinib hydrochloride
Process for the preparation of Isosulfan Blue
Process for the preparation of Isosulfan Blue
Process for the preparation of Isosulfan Blue
Process for the preparation of Isosulfan Blue
Process of Making Regadenoson and Novel Polymorphs Thereof
Processes for Making Ponatinib
Application:
61/824,070 →
Methods of Making Netupitant
Application:
61/988,434 →
Methods of Making Netupitant
Application:
62/045,884 →
Methods of Making Carfilzomib and Intermediates Thereof
Application:
62/068,928 →
Process of Making Regadenoson and Novel Polymorphs Thereof
Application:
62/112,680 →
Processes for Making Ponatinib and Intermediates Thereof
Application:
62/174,083 →
Processes for Making Ponatinib and Intermediates Thereof
Application:
62/175,721 →
Process of Making Regadenoson and Novel Polymorphs Thereof
Application:
62/187,977 →
Processes for Making Ponatinib and Intermediates Thereof
Application:
62/204,571 →
Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
Application:
62/440,708 →
Novel polymorphs of ponatinib hydrochloride
Application:
62/448,787 →
Sincalide Formulations and Methods of Use
Application:
62/520,254 →
Non-Polymeric Extended Release Molindone Compositions
Application:
62/530,604 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 27, 2007
From: NAMPALLI, SATYAM; PATEL, BRIJESH; THARIAL, PETER XAVIER; KOVI, RAVISHANKER
To: APICORE, LLC
Reel/Frame 019486/0533 →
Assignment of Assignor's Interest
Jun 29, 2007
From: KOVI, RAVISHANKER; NAMPALLI, SATYAM; THARIAL, PETER XAVIER
To: APICORE, LLC
Reel/Frame 019497/0722 →
Assignment of Assignor's Interest
Sep 1, 2010
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; CHOWDARI, TALLURI BUHSHAIAH; SHAH, CHIRAG VASANTLAL
To: APICORE, LLC
Reel/Frame 024922/0407 →
Assignment of Assignor's Interest
Dec 14, 2011
From: KOVI, RAVISHANKER; NAIK, ASHISH; PATEL, BRIJESH; MADALA, MURALIKRISHNA
To: APICORE, LLC
Reel/Frame 027385/0889 →
Security Interest
Jul 3, 2014
From: APICORE LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033277/0320 →
Assignment of Assignor's Interest
Jul 7, 2014
From: APICORE LLC
To: APICORE US LLC
Reel/Frame 033254/0007 →
Security Interest
Jul 8, 2014
From: APICORE US LLC
To: KNIGHT THERAPEUTICS INC., AS AGENT
Reel/Frame 033281/0920 →
Merger and Change of Name
Jul 15, 2014
From: APICORE LLC; APICORE US LLC
To: APICORE US LLC
Reel/Frame 033315/0712 →
Assignment of Assignor's Interest
Oct 3, 2014
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F.; PATEL, RAJESH A.
To: APICORE US LLC
Reel/Frame 033878/0369 →
Assignment of Assignor's Interest
Sep 28, 2015
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F.; NAIK, ASHISH
To: APICORE US LLC
Reel/Frame 036671/0654 →
Assignment of Assignor's Interest
Nov 25, 2015
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; RAMU, VASANTHAKUMAR G.; PRASAD, ALAPARTHI LAKSHMI
To: APICORE US LLC
Reel/Frame 037143/0300 →
Assignment of Assignor's Interest
Apr 4, 2016
From: KOVI, RAVISHANKER; NAIK, ASHISH; FADADU, PIYUSH; KANNAPAN, JAYARAMAN
To: APICORE US LLC
Reel/Frame 038186/0264 →
Release of Security Interest
Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE LLC
Reel/Frame 040904/0362 →
Release of Security Interest
Jan 9, 2017
From: KNIGHT THERAPEUTICS INC.
To: APICORE US LLC
Reel/Frame 040904/0390 →
Security Interest
Jan 31, 2017
From: APICORE US LLC
To: MEDICURE INC.
Reel/Frame 041577/0821 →
Release of Security Interest
Jul 17, 2017
From: MEDICURE INC.
To: APICORE US LLC
Reel/Frame 043022/0696 →
Assignment of Assignor's Interest
Sep 29, 2017
From: KOVI, RAVISHANKER; KANNAPAN, JAYARAMAN; THAKOR, SANJAY F; PATEL, RAJESH A
To: APICORE US LLC
Reel/Frame 043740/0143 →
Assignment of Assignor's Interest
Nov 2, 2017
From: APICORE LLC
To: APICORE US LLC
Reel/Frame 044016/0764 →
Assignment of Assignor's Interest
Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN LABORATORIES LIMITED
Reel/Frame 057685/0916 →
Assignment of Assignor's Interest
Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN PHARMACEUTICALS INC.
Reel/Frame 057686/0024 →
Assignment of Assignor's Interest
Oct 4, 2021
From: MYLAN API US LLC
To: MYLAN INSTITUTIONAL LLC
Reel/Frame 057686/0088 →
Assignment of Assignor's Interest
Jul 8, 2026
From: MYLAN PHARMACEUTICALS INC.
To: MYLAN LABORATORIES LIMITED
Reel/Frame 075206/0497 →
Assignment of Assignor's Interest
Jul 16, 2026
From: MYLAN LABORATORIES LIMITED
To: MATRIX PHARMACORP PRIVATE LIMITED
Reel/Frame 075291/0584 →